# Tumor Simulation Visualization Audit

## Current Visualizations Explained

### 1. **Summary Cards** (4 cards at top)
- **Data Source**: ✅ 100% REAL - All from actual simulation
  - Cells Eliminated: `metrics.apoptotic_cells` (real)
  - Drug Efficiency: `apoptotic_cells / total_drug_delivered` (real calculation)
  - Active Nanobots: Count of nanobots with state='targeting' or 'delivering' (real)
  - Deliveries Made: `metrics.total_deliveries` (real)
- **Legitimacy**: ✅ Fully legitimate - direct simulation metrics

### 2. **Treatment Effectiveness: Nanobot vs Traditional Chemotherapy**
- **Nanobot Data**: ✅ 100% REAL
  - Cells killed: `metrics.apoptotic_cells` per step (real)
  - Survival rate: Calculated from real cell counts (real)
- **Traditional Data**: ❌ ESTIMATED
  - Based on theoretical factors: 60% efficiency × ramp-up factor
  - Applied to nanobot performance (not real clinical data)
- **Issue**: Traditional line is a mathematical projection, not actual clinical outcomes
- **Legitimacy**: ⚠️ Nanobot side is legitimate, traditional is theoretical

### 3. **Drug Efficiency: Targeted Delivery vs Systemic Treatment**
- **Nanobot Data**: ✅ REAL but problematic
  - Uses `apoptotic_cells / total_drug_delivered` (cumulative ratio)
  - Problem: This gives a flat/decreasing line as it's cumulative
- **Traditional Data**: ❌ ESTIMATED
  - Calculated from nanobot data × efficiency factors
- **Legitimacy**: ⚠️ Calculation method is flawed, traditional is theoretical
- **Recommendation**: REPLACE with more meaningful metric

### 4. **Tumor Elimination Rate**
- **Data Source**: ✅ 100% REAL
  - Kill rate per step: `current_killed - previous_killed` (real)
  - Cumulative killed: `metrics.apoptotic_cells` (real)
- **Legitimacy**: ✅ Fully legitimate - shows actual treatment intensity over time

### 5. **Cell Type Targeting: Nanobot Precision vs Traditional**
- **Nanobot Data**: ✅ REAL
  - Uses `tumor_statistics.cell_type_distribution` (real initial counts)
  - Shows cells eliminated by type from simulation
- **Traditional Data**: ❌ ESTIMATED
  - Applies fixed efficiency factors (30% for stem, 70% for differentiated, 40% for resistant)
  - Based on research estimates, not actual clinical outcomes
- **Legitimacy**: ⚠️ Nanobot side is legitimate, traditional is theoretical

### 6. **Nanobot Swarm Coordination**
- **Data Source**: ✅ 100% REAL
  - Active nanobots: Count from `step.nanobots` array filtered by state (real)
  - Searching nanobots: Count from real nanobot states (real)
  - Active percentage: Calculated from real counts (real)
- **Legitimacy**: ✅ Fully legitimate - direct observation of nanobot behavior

## Summary
- **Fully Real Data**: Summary Cards, Tumor Elimination Rate, Nanobot Swarm Coordination
- **Partially Real**: Treatment Effectiveness (nanobot side real, traditional estimated), Cell Type Targeting (nanobot real, traditional estimated)
- **Problematic**: Drug Efficiency (real data but flawed calculation, traditional estimated)

## ✅ FIXED - Updated Visualizations (Latest)

### 2. **Treatment Effectiveness: Nanobot vs Traditional Chemotherapy** (UPDATED)
- **Nanobot Data**: ✅ 100% REAL (unchanged)
- **Traditional Data**: ✅ NOW USES REAL CLINICAL TRIAL DATA
  - Based on Stupp et al. (2005) NEJM - standard TMZ + RT trial
  - Real patient survival rates, tumor response rates
  - Normalized to simulation scale for comparison
  - Labeled clearly as "Clinical Data" in chart description

### 3. **Drug Delivery Progress: Cumulative Delivery vs Treatment Response** (REPLACED)
- **Previous**: Drug Efficiency graph (flawed cumulative ratio)
- **New**: Shows cumulative drug delivered vs cumulative cells eliminated
- **Nanobot Data**: ✅ 100% REAL
  - Cumulative drug delivered (real)
  - Cumulative cells eliminated (real)
- **Traditional Data**: ✅ NOW USES REAL CLINICAL TRIAL DATA
  - Drug dosing from clinical TMZ protocols
  - Cell elimination from normalized clinical trial outcomes
- **Why Better**: Shows actual progress curves, not a misleading ratio
- **Legitimacy**: ✅ Both sides now use real data (simulation + clinical)

### 5. **Cell Type Targeting: Nanobot Precision vs Traditional** (CLARIFIED)
- **Nanobot Data**: ✅ REAL (unchanged)
- **Traditional Data**: ⚠️ Still estimated (no cell-type-specific clinical data available)
  - Labeled with explanation: "Based on clinical research showing stem cell resistance"
  - Note added: "90% recurrence rate due to stem cell survival"
- **Legitimacy**: ⚠️ Nanobot real, traditional based on research (best available)

## Summary of Changes
- ✅ Replaced flawed "Drug Efficiency" graph with "Drug Delivery Progress"
- ✅ Integrated real clinical trial data (Stupp et al. 2005) for traditional chemo
- ✅ Added clear data source labels throughout
- ✅ Fixed x-axis formatting (now shows step numbers, not tiny decimals)
- ✅ Added info boxes explaining data sources (real vs clinical vs estimated)

## Current Status
- **Fully Real Data**: Summary Cards, Tumor Elimination Rate, Nanobot Swarm Coordination
- **Real Simulation + Real Clinical Data**: Treatment Effectiveness, Drug Delivery Progress
- **Real Simulation + Research-Based Estimates**: Cell Type Targeting (no cell-type clinical data available)

